ECM or Intact-Cell Selection
Screen purified components, composite/cell-deposited ECM, intact cells, or combined surface systems.
Creative Biolabs maps ECM and cell-surface interactomes by phage display with subtractive screening, specificity panels, and receptor or functional follow-up.
Complex extracellular matrix and intact cell surfaces can preserve biological features that purified-protein assays miss, but they also create strong nonspecific-enrichment risks. Creative Biolabs applies phage display protein interaction mapping to purified ECM components, composite or cell-deposited matrix, intact target cells, or matched surface systems, with depletion and specificity controls designed around the biological contrast of interest.
The screen can prioritize sequence families that prefer a target matrix or cell state, then retest them against related surfaces and in a non-phage molecular format. Depending on the project endpoint, outputs can stop at a selectively binding ligand or continue—when separately scoped—toward receptor deconvolution or a dedicated functional assay. This makes the negative surface as important as the positive surface when the goal is to distinguish useful selectivity from generic charge, plastic, glycan, or abundant-surface binding.
Projects centered on a recovered receptor can connect to orphan receptor ligand screening, while a compact sequence-level recognition question can move toward binding motif identification. The ECM/cell-surface route is most useful when the selected feature emerges from a biologically meaningful positive-versus-negative comparison.
Screen purified components, composite/cell-deposited ECM, intact cells, or combined surface systems.
Remove predictable plastic, carrier, related-matrix, or shared-cell-surface binders.
Compare enriched candidates across positive, negative, and related surfaces and retest selected sequences as synthesized or reformatted molecules.
Add receptor deconvolution or dedicated functional assays only when separately scoped and needed for the research decision.
| False-Enrichment Risk | Control Strategy | What the Control Helps Reveal |
|---|---|---|
| Plastic, bead, tag, or carrier binding | Material-only pre-depletion or parallel control | Assay-surface binders unrelated to the biological target. |
| Generic ECM stickiness or charge | Related-matrix and chemically similar surface panel | Broad adsorption rather than specific matrix recognition. |
| Broad cell-surface binding | Target-negative or closely related cell population | Candidates that recognize common membrane features. |
| Phage-particle avidity | Synthetic peptide or soluble/reformatted candidate retest | Whether binding belongs to the sequence outside the multivalent phage context. |
| Apparent adhesion/migration effect | Viability and cell-count controls | Whether cell loss or growth changes explain the phenotype. |
A strong ECM or intact-cell screen is built around the negative surfaces that explain false enrichment. We use pre-depletion and matched specificity panels to distinguish a candidate that tracks with the intended matrix or cell state from one that simply binds plastic, charge, common ECM components, or abundant cell-surface features.
| Screening Surface | Best Suited For | Key Control Need |
|---|---|---|
| Purified ECM component | Ligands to collagen, laminin, fibronectin, proteoglycans, or another defined matrix molecule. | Related-matrix proteins, carrier/capture surface, and material-only controls. |
| Composite or cell-deposited ECM | Recognition of matrix context that depends on composition or assembly. | Matched matrix preparations and controls for charge, crosslinking, and preparation method. |
| Intact target cells | Native membrane topology, glycans, multicomponent surface recognition, or state-selective binding. | Closely matched target-negative/related cells plus viability and surface-density considerations. |
| Cells on a defined matrix | Questions that connect cell surface and matrix interaction. | Separate cell, matrix, and combined controls so the selected feature can be interpreted. |
Matrix preparations are not interchangeable. Purified collagen, laminin, fibronectin, decellularized matrix, and cell-deposited ECM differ in composition, conformation, crosslinking, accessibility, and charge. A peptide selected on one preparation may not recognize the same molecule in another structural context. We therefore document the material used and, when specificity matters, confirm candidates against independent or related matrix preparations.
Intact cells preserve native membrane presentation but create a different challenge: abundant housekeeping proteins, glycans, lipids, and cell-state-dependent surface changes can dominate recovery. Subtractive selection works best when the negative cell population is biologically close enough to remove shared background while preserving the feature of interest. Differences in cell size, viability, passage, activation state, and target abundance are considered during interpretation.
Workflow at a Glance: Define positive & negative surfaces → Deplete predictable background → Select & specificity-retest → Reformat / optional target-function.
Document matrix composition or cell state, target-positive and target-negative materials, library format, blocking conditions, specificity requirements, and downstream use.
Use plastic, carriers, tags, related matrices, or control cells to remove recurrent nonspecific binders, then expose the library to the intended ECM or cell surface under material-appropriate conditions.
Use clone sequencing or NGS to identify recurring motifs and sequence families across rounds, replicate selections, and depletion conditions.
Compare individual clones across related and target-negative surfaces, then synthesize peptides or express/reformat antibody fragments to separate intrinsic recognition from phage-particle avidity.
Where scientifically appropriate, use competition, affinity capture, crosslinking, expression perturbation, adhesion, spreading, migration, or another suitable assay according to the next research question.
Intact-cell selection can generate a cell-selective ligand without revealing the receptor. The selected sequence may recognize a protein, glycan, lipid-associated structure, matrix deposited on the surface, or a multicomponent feature. We do not infer receptor identity from cell binding alone. If deconvolution is required, we plan enough candidate material and suitable controls for affinity capture, competition, crosslinking, recombinant-candidate testing, expression perturbation, or another method appropriate to the system.
A useful deconvolution result should explain the original selectivity. If a candidate binds a proposed recombinant receptor but also recognizes receptor-negative cells or unrelated matrix surfaces, the model remains incomplete. We therefore connect target identification back to the original positive/negative comparison instead of treating any isolated biochemical interaction as a final answer.
Multivalent display can increase apparent avidity and may not predict monomeric behavior.
Synthetic peptide or soluble/reformatted material tests whether recognition persists outside the phage-particle context.
Orientation and ligand density can change accessibility and avidity, so confirmation should reflect the intended downstream presentation when that difference matters.
For composite matrices, preparation method and composition are especially important because they influence the features available to the library. Selective binding, receptor identification, and biological modification should remain separate outputs.
Cheung and colleagues used phage display to identify peptides with preferential binding to chondrocytes and cartilage-associated extracellular matrix. Selected phage clones were followed by testing of corresponding synthetic peptides, providing an example of how complex-surface discovery can move from phage enrichment to a non-phage ligand format. The work also highlights the value of considering both cell-associated and matrix-associated recognition when the biological surface is heterogeneous.
For ECM and cell-surface projects, this published study supports two practical principles used by Creative Biolabs: complex-surface selection needs specificity controls, and promising sequences should be retested outside the phage particle. Receptor identification or functional effects remain separate questions that can be added after selective binding is established.
Send us your ECM or cell materials, positive and negative surfaces, known receptors, library format, specificity requirements, final candidate presentation, and any receptor-deconvolution or functional goal. Creative Biolabs can help you build a research-use screen that separates specific recognition from generic stickiness and connects selected ligands to the right next experiment.
Discuss Your Project
Please kindly note that our services can only be used to support research purposes (Not for clinical use).
Creative Biolabs is a globally recognized phage company. Creative Biolabs is committed to providing researchers with the most reliable service and the most competitive price.
